Sulfonamide Inhibition Studies of the β-Class Carbonic Anhydrase CAS3 from the Filamentous Ascomycete


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
25 Feb 2020
Historique:
received: 10 02 2020
revised: 23 02 2020
accepted: 23 02 2020
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 2 12 2020
Statut: epublish

Résumé

A new β-class carbonic anhydrase was cloned and purified from the filamentous ascomycete

Identifiants

pubmed: 32106611
pii: molecules25051036
doi: 10.3390/molecules25051036
pmc: PMC7179226
pii:
doi:

Substances chimiques

Carbonic Anhydrase Inhibitors 0
Sulfonamides 0
Thiazines 0
Sulfanilamide 21240MF57M
brinzolamide 9451Z89515
Carbonic Anhydrases EC 4.2.1.1
Benzolamide FC5AAH89R5
Acetazolamide O3FX965V0I
Methazolamide W733B0S9SD
Ethoxzolamide Z52H4811WX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Metabolites. 2017 Nov 11;7(4):
pubmed: 29137134
J Med Chem. 2012 Jun 14;55(11):5529-35
pubmed: 22578027
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1537-1544
pubmed: 30284487
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
Acta Crystallogr D Biol Crystallogr. 2015 Dec 1;71(Pt 12):2449-56
pubmed: 26627652
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1156-61
pubmed: 26523349
Expert Opin Ther Pat. 2019 Oct;29(10):781-792
pubmed: 31596641
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6327-31
pubmed: 18993072
Expert Opin Ther Pat. 2018 Oct;28(10):713-721
pubmed: 30175635
Expert Opin Drug Discov. 2017 Jan;12(1):61-88
pubmed: 27783541
Expert Opin Ther Pat. 2019 Oct;29(10):745-747
pubmed: 31566015
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Bioorg Med Chem. 2009 Jul 1;17(13):4503-9
pubmed: 19450983
PLoS One. 2009;4(4):e5177
pubmed: 19365544
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
J Med Chem. 2009 May 14;52(9):3116-20
pubmed: 19338333
Expert Opin Ther Pat. 2018 Oct;28(10):709-712
pubmed: 30217119
Expert Opin Drug Discov. 2019 Nov;14(11):1175-1197
pubmed: 31436118
Metabolites. 2020 Jan 16;10(1):
pubmed: 31963335
Mol Microbiol. 2014 Jun;92(5):931-44
pubmed: 24720701
J Enzyme Inhib Med Chem. 2018 Dec;33(1):390-396
pubmed: 29363370
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Curr Top Med Chem. 2007;7(9):901-8
pubmed: 17504135
Expert Opin Ther Pat. 2012 Jul;22(7):747-58
pubmed: 22697257
ACS Cent Sci. 2019 Feb 27;5(2):308-318
pubmed: 30834319
Expert Opin Ther Pat. 2018 Oct;28(10):745-754
pubmed: 29973089
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1064-1070
pubmed: 28766952
Curr Genet. 2009 Apr;55(2):211-22
pubmed: 19296112
Adv Genet. 2014;87:199-244
pubmed: 25311923
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
FEBS J. 2014 Apr;281(7):1759-72
pubmed: 24506675
Expert Opin Emerg Drugs. 2012 Mar;17(1):11-5
pubmed: 22335448
Bioorg Med Chem Lett. 2004 Sep 6;14(17):4563-7
pubmed: 15357993
Microbiology. 2010 Jan;156(Pt 1):23-9
pubmed: 19833770
J Mol Biol. 2009 Jan 30;385(4):1207-20
pubmed: 19071134
Expert Opin Investig Drugs. 2018 Dec;27(12):963-970
pubmed: 30426805

Auteurs

Daniela Vullo (D)

Dipartimento di Chimica Ugo Schiff, Università degli Studi di Firenze, 50019 Sesto Fiorentino (Florence), Italy.

Ronny Lehneck (R)

Institute of Microbiology and Genetics, Department of Genetics of Eukaryotic Microorganisms, Georg-August-University, 37077 Gottingen, Germany.

William A Donald (WA)

University of New South Wales, School of Chemistry, Sydney, NSW 2052, Australia.

Stefanie Pöggeler (S)

Institute of Microbiology and Genetics, Department of Genetics of Eukaryotic Microorganisms, Georg-August-University, 37077 Gottingen, Germany.

Claudiu T Supuran (CT)

University of New South Wales, School of Chemistry, Sydney, NSW 2052, Australia.
Neurofarba Dept., Section of Pharmaceutical and Nutriceutical Sciences, Università degli Studi di Firenze, 50019 Sesto Fiorentino (Florence), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH